MYC and lymphoma: While genetic studies have shown that Apaf-1 and/or caspase-9 deletion promote Myc-induced oncogenic transformation of MEFs, in vivo deletion of these genes reportedly had no effect on the rate, severity, or chemotherapeutic response of Myc-induced lymphomas [125,126].